Millions of women to gain from price cut for contraceptive implants


Millions of women to gain from price cut for contraceptive implants
Millions of women to gain from price cut for contraceptive implants
Solange Lamousa – a Community Health Agent introduces and distributes contraceptive methods to the family of Sibini Abibou Sawodogo in Sablogo Village located 28 km from Tenkodogo, Burkina Faso. © UNFPA/Ollivier Girard

A group of public and private sector partners agreed in 2013 on a 50 per cent price reduction for two contraceptive implants, which will translate in millions of women in developing countries gaining more access to contraceptives.

One of the agreements includes reducing the cost of Jadelle® contraceptive implants from US$ 18 to US$8.50 per unit in more than 50 countries, some of which deemed least likely to meet the Millennium Development Goals. The initiative alone could avert more than 28 million unintended pregnancies between 2013 and 2018, and, ultimately, prevent approximately 280,000 child and 30,000 maternal deaths.

Under a second agreement, the cost of IMPLANON® and its next generation implant IMPLANON®NXT is being reduced by approximately 50 per cent over the next six years in the same set of countries. The agreement foresees a partnership with the Reproductive Health Supplies Coalition to provide 4.5 million women in developing countries, with increased access to the contraceptive.

Today, more than 220 million women and girls in poor countries who do not want to get pregnant lack access to modern contraceptives. Studies have shown that of the 600 million women in non-industrialized nations who are using modern contraceptive methods, only 1 to 2 per cent use implants. However, a significantly higher proportion would choose implants if they were consistently available, affordable and supported by counseling and clinical services. In many programs where implants are offered today, they are one of the fastest growing methods of choice.

These two price reduction agreements built on the momentum generated at the July 2012 London Summit on Family Planning, where world leaders committed to provide an additional 120 million women in the world’s poorest countries with voluntary access to modern contraceptives by 2020. The agreements also support the UN Commission on Life-Saving Commodities’ efforts to improve access to and use of essential but overlooked supplies for women’s and children’s health.

Read the MSD press release

Read the Bayer press release


Leave a Reply

Your email address will not be published. Required fields are marked *


4 − = 3